BA vs BNGO · P/E 89, rev $24.56B vs rev $14.9M
The Boeing Company (BA) versus Bionano Genomics Inc (BNGO) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
Latest reported BA revenue for 2026-06-30 was $24.56B. Net income was -$444.0M. Revenue was up 10.5% from 2026-03-31 to 2026-06-30. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported BNGO revenue for 2026-06-30 was $14.9M. Net income was -$15.7M. BNGO currently screens at market cap $13.4M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. BNGO currently screens at market cap $13.4M.
Not investment advice. Open the BA and BNGO stock pages for the full models.
Not investment advice.